Navigation Links
First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure
Date:4/21/2009

The Ohio State University Medical Center Implants Two Patients with Sunshine Heart's C-Pulse(TM) Heart Assist System Under FDA-Approved Clinical Trial

SYDNEY, and TUSTIN, Calif., April 21 /PRNewswire/ -- Sunshine Heart (ASX: SHC), a global medical device company focused on innovative heart assist technologies, announced today that The Ohio State University Medical Center in Columbus, Ohio has successfully completed the first two implants of the Company's C-Pulse(TM) heart assist system under a 20 person clinical trial approved by the U.S. Food and Drug Administration (FDA).

These C-Pulse systems were implanted by Dr. Benjamin Sun, Chief, Division of Cardiothoracic Surgery and Director, Cardiac Transplantation and Mechanical Support.

"It is an honor to have completed the first U.S. implants of the C-Pulse heart assist system," said Dr. Sun. "C-Pulse is highly innovative and implanted with a simple, low-risk minimally invasive surgical procedure. The device has the potential to offer a new therapy option for the treatment of moderate heart failure."

"We are excited that our clinical trial in the U.S. has started so successfully," said Dr. William Peters, Medical Director of Sunshine Heart and the inventor of C-Pulse. "We have demonstrated in prior clinical studies that the C-Pulse system increases blood flow to the body and to the heart muscle itself. We anticipate that C-Pulse will offer patients a significant improvement in quality of life." Dr. Peters went on to point out importantly that the device operates without coming into direct contact with the blood, so avoiding potential complications with systems that do contact blood. A feature of the design of the C-Pulse is that patients can safely disconnect from the device for short periods for their convenience."

"The completion of the initial C-Pulse implants in the U.S. is a major milestone for Su
'/>"/>

SOURCE Sunshine Heart
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. The ASDS Introduces the First At-Home Skin Cancer Exam Kit
2. Quest Diagnostics Reports Strong Earnings Growth In First Quarter 2009
3. Worlds First Disposable Wireless RFID Sensor Detects Radiation Threats in Shipping Containers Using Modified Cell Phone Technology
4. Schering-Plough Reports Financial Results for 2009 First Quarter
5. Stereotaxis Announces First Quarter 2009 Earnings Release Date and Conference Call
6. Boston Scientific Announces Results For First Quarter Ended March 31, 2009
7. Young Innovations, Inc. Provides First Quarter Conference Call Details
8. Insulet Corporation to Report First Quarter 2009 Financial Results on Thursday, May 7, 2009
9. Lincare Holdings Inc. Announces First Quarter 2009 Financial Results
10. Amgen Announces Webcast of 2009 First Quarter Financial Results
11. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 27, 2009 to Discuss First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... German . , ... their mode of action is complex: In low concentrations ... while at high concentrations they can cause "oxidative stress", ... redox signaling unfolds in single cells and organelles in ... jointly by the teams of LMU Professor Martin Kerschensteiner ...
(Date:4/22/2014)... (SALT LAKE CITY)A computational tool developed at the University ... with unknown gene mutations in three separate cases, U ... new study in The American Journal of Human ... Re-ranking tool), identifies undiagnosed illnesses and unknown gene mutations ... proteins that code for genes are made, in individual ...
(Date:4/22/2014)... nanodot technology, Berkeley Lab researchers have demonstrated the ... used to study the membranes of living cells. ... structures can reveal information critical to whether a ... cancerous, that can,t be obtained through conventional microscopy. ... provide a physical means to both probe and ...
(Date:4/22/2014)... -- In parallel with modern man ( Homo sapiens ), ... we lived side by side, such as Neanderthals and the ... sapiens survived. What was it in our genetic makeup ... little is known about our unique genetic makeup as distinguished ... fact that we are the only species among them ,to ...
(Date:4/22/2014)... may throw tantrums like toddlers, but their total ... say, a gerbil or fox squirrel, according to ... and birds ranging from orangutans to zebra finches. ... Yale and more than two-dozen other research institutions ... evolution of self-control, defined in the study as ...
Breaking Medicine News(10 mins):Health News:Neuroimaging: Live from inside the cell 2Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 2Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 3Health News:First size-based chromatography technique for the study of livi 2Health News:First size-based chromatography technique for the study of livi 3Health News:What gave us the advantage over extinct types of humans? 2Health News:Brain size matters when it comes to animal self-control 2Health News:Brain size matters when it comes to animal self-control 3
... NEW DELHI: The government of India has today assured that ... in the country // ,The government has ... eye on the on the domestic poultry population and migratory ... and take appropriate action as and when required. ...
... is to fund ?28m for research in United Kingdom ... for the eradication of Malaria worldwide. Bill Gates along ... three // international projects for malaria eradication over the ... funding is contributed to research of AIDS and cancer, ...
... there maybe gender difference of the risk of tobacco for ... at higher risk of developing the cancer. //, ... presented her findings at the 70th Annual Scientific Meeting ... smoking and alcohol use are well-established risk factors for colorectal ...
... Forest University Baptist Medical Center have found a new treatment ... found that the inactive form of EphA2 // protein in ... and the work was published in the Journal Molecular Cancer ... tumor and the least curable of all human cancers. ...
... to investigate the association among non-insulin-dependent diabetes, bone mineral ... that diabetic women have a higher bone mineral // ... between osteoporosis and cardiovascular risk factors in diabetics. , ... Type II diabetics have bone mass alterations and may ...
... is one of the most common cancers occurring in ... Eloxatin drug with other chemotherapeutic cancer drug for treatment ... reduced recurrence in these patients. This study which is ... Eloxatin with chemotherapeutic drugs more effective than control group ...
Cached Medicine News:Health News:Bill Gates to Fund ?28m for Malaria researc 2Health News:Women More Prone To Risk of Colorectal Cancer from Tobacco 2Health News:Protein Markers for Identification of Brain Tumor 2Health News:Diabetic Type II Women Have Elevated Bone Density Mass 2
(Date:1/15/2014)... , Jan. 15, 2014 As health officials across ... virus, select Meijer pharmacies in Michigan ... to eligible patients, enabling Meijer pharmacists to administer tests and, ... set by a physician participating in the study. ...
(Date:1/15/2014)... , Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... received commitments from institutional investors to purchase an aggregate ... in an at-the-market registered direct offering, led by a ... into definitive purchase agreements with these investors pursuant to ...
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive a ... of Drugs in Dermatology (JDD) at the upcoming ... is January 17-20, 2014, at the Omni Orlando Resort at ChampionsGate ... The ODAC is a distinguished event that delivers a ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... 2011 BioSpecifics Technologies Corp. (Nasdaq: BSTC ... class collagenase-based products, today announced that its Board of ... the Company is authorized to repurchase up to $2 ... the Company,s continued commitment to increasing value for its ...
... 2011 Reportlinker.com announces that a new ... catalogue: Top Medical Devices ... http://www.reportlinker.com/p0558499/Top-Medical-Devices-and-Imaging-Technologies-2011.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices This research ... technologies that have excellent growth potential in ...
Cached Medicine Technology:BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Share Repurchase Program 2BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Share Repurchase Program 3Reportlinker Adds Top Medical Devices and Imaging Technologies 2011 2
Supplied sterile in peel-open packages. Intended for one-time use....
Used as a percutaneous entry needle to introduce wire guides. The coaxial design reduces potential A.V. malformations. Supplied sterile in peel-open packages. Intended for one-time use....
... affordable, high-quality light guide cables work in ... provide optimal brightness during a number of ... give you the flexibility and ease-of-use necessary ... is fully-autoclavable so they can be easily ...
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
Medicine Products: